...
首页> 外文期刊>Critical care medicine >Surfactant protein-B polymorphisms and mortality in the acute respiratory distress syndrome.
【24h】

Surfactant protein-B polymorphisms and mortality in the acute respiratory distress syndrome.

机译:表面活性剂蛋白B多态性与急性呼吸窘迫综合征的死亡率。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

OBJECTIVE: To determine whether polymorphisms of the surfactant protein B gene may be associated with increased mortality in patients with the acute respiratory distress syndrome. DESIGN: A prospective cohort study. SETTING: Four adult intensive care units at a tertiary academic medical center. PATIENTS: Two hundred fourteen white patients who had met criteria for acute respiratory distress syndrome. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Patients were genotyped for a variable nuclear tandem repeat polymorphism in intron 4 of the surfactant protein B gene and the surfactant protein B gene +1580 polymorphism. For the variable nuclear tandem repeat surfactant protein B gene polymorphism, patients were found to have either a homozygous wild-type genotype or a variant genotype consisting of either a heterozygous insertion or deletion polymorphism. Logistic regression was performed to analyze the relationship of the polymorphisms to mortality in patients with acute respiratory distress syndrome. In multivariate analysis, the presence of variable nuclear tandem repeat surfactant protein B gene polymorphism was associated with a 3.51 greater odds of death at 60 days in patients with acute respiratory distress syndrome as compared to those patients with the wild-type genotype (95% confidence interval 1.39-8.88, p = 0.008). There was no association found between the +1580 variant and outcome (p = 0.15). CONCLUSIONS: In this study, the variable nuclear tandem repeat surfactant protein B gene polymorphism in intron 4 is associated with an increased 60 day mortality in acute respiratory distress syndrome after adjusting for age, severity of illness, and other potential confounders. Additional studies in other populations are needed to confirm this finding.
机译:目的:确定表面活性剂蛋白B基因的多态性是否与急性呼吸窘迫综合征患者死亡率增加有关。设计:一项前瞻性队列研究。地点:三级学术医学中心的四个成人重症监护室。患者:符合急性呼吸窘迫综合征标准的241位白人患者。干预措施:无。测量和主要结果:对患者的基因型进行了表面活性剂蛋白B基因内含子4和表面活性剂蛋白B基因+1580多态性的可变核串联重复序列多态性的基因分型。对于可变核串联重复序列表面活性剂蛋白B基因多态性,发现患者具有纯合的野生型基因型或由杂合的插入或缺失多态性组成的变异基因型。进行逻辑回归分析以分析多态性与急性呼吸窘迫综合征患者死亡率之间的关系。在多变量分析中,与野生型基因型患者相比,急性呼吸窘迫综合征患者在60天时可变核串联重复序列表面活性剂蛋白B基因多态性的存在与3.51更大的死亡几率相关(95%可信度)区间1.39-8.88,p = 0.008)。在+1580变量与结果之间未发现关联(p = 0.15)。结论:在这项研究中,在调整了年龄,疾病的严重程度和其他潜在的混杂因素后,内含子4中可变的核串联串联重复表面活性剂蛋白B基因多态性与急性呼吸窘迫综合征60天死亡率增加有关。需要在其他人群中进行其他研究以证实这一发现。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号